Study identifies benefits, risks linked to popular weight-loss drugs | WashU Medicine
GLP-1 medications tied to decreased risk of dementia, addiction; increased risk of kidney, pancreas and gastrointestinal problems
Related Articles
Potential targeted therapy for pediatric brain cancer identified by Dana-Farber/Boston Children’s team | Dana-Farber Cancer Institute
An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in…
Suicidal ideation significantly higher among childhood cancer survivors
Childhood cancer survivors in Europe exhibited higher risk for suicidal ideation than the general population, according to results of a systematic review and meta-analysis.This finding…
Clinical Scenario 1: A HER2+ mBC Patient With Trastuzumab Deruxtecan With Brain Mets
Panelists discuss how trastuzumab deruxtecan (Enhertu) is used to treat HER2-positive metastatic breast cancer with brain metastases, emphasizing its effectiveness in achieving systemic tumor reduction…
Peritumoral edema resolves infrequently in surgically treated patients with intracranial meningioma– a retrospective study of 279 meningioma patients
Journal of Neuro-Oncology – The resolution of peritumoral brain edema (PTBE) following surgery for intracranial meningioma (IM) is poorly understood. We hypothesized that PTBE represents…
ASTROgram for week of March 17- American Society for Radiation Oncology (ASTRO)
ASTRO’s weekly member newsletter for the week of March 17: ROCR Act reintroduced, Don’t miss 2025 Refresher, Leadership Pathway Program Awardees
Genomic Summary Results | EGRP/DCCPS/NCI/NIH
Resources for investigators to find and make publicly available genomic summary results (GSR) data from cancer research studies.
Artificial Intelligence (AI) Model, “HistoTME,” Aids in Predicting Response to Immunotherapy | CBIIT
NCI researchers debuted a new deep learning model that could help you decipher the cancer tumor’s microenvironment. The model holds a lot of promise for…
Diagnosis and Risk Stratification for Early-Stage HR+/HER2- Breast Cancer
Panelists discuss how the NCCN guidelines for risk stratification in HR+/HER2- early-stage breast cancer inform clinical decision-making, with an emphasis on biomarker testing, the use…
Automated Follow-up Alerts Pharmacists to Cancer Patients’ Needs
Early automated follow-up of cancer patients can help pharmacists more efficiently manage side effects of oral oncolytic medications, according to data presented at the ASHP…
Keytruda Receives Traditional Approval for Some Patients With HER2-Positive Gastric or GEJ Adenocarcinoma
The FDA has granted traditional approval to pembrolizumab (Keytruda, Merck) with trastuzumab, fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of adults with locally advanced…